Latest AI and machine learning research in genetics for healthcare professionals.
BACKGROUND: Early detection of cancer and precise recurrence monitoring remain major unmet needs in oncology. Conventional screening is limited to a few cancer types, leaving nearly half of cancers without established programs. Multi-cancer early detection (MCED) tests based on circulating tumor biomarkers have shown promise, but sensitivity for early-stage remains a challenge. In parallel, detect...
It is well known that bipolar disorder (BD) and epilepsy (EP) are common neurological diseases. The objective of this study was to screen for potential biomarkers applicable to the diagnosis of EP and BD. The gene expression profiles from both the BD and EP datasets were sourced from the Gene Expression Omnibus database. To pinpoint the core shared genes, we conducted differential expression analy...
MicroRNAs (miRNAs) serve as crucial biomarkers in disease diagnosis. Although silicon-based electronic machine learning models provide efficient means...
PURPOSE: Personalized immunotherapy strategies are urgently needed for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We aim to...
Liquid biopsies and cell-free DNA (cfDNA) offer minimally invasive methods for the diagnosis and monitoring of Ewing Sarcoma (EwS). EwS have a low tum...
BACKGROUND: Sepsis is a leading cause of critical illness and mortality, yet substantial heterogeneity limits risk stratification and biomarker transl...
BACKGROUND AND AIMS: To identify novel biomarkers and therapeutic targets for polycystic ovary syndrome (PCOS) using integrated bioinformatics approac...
Brucellosis is an important zoonotic disease affecting humans, livestock, and wildlife, yet prevalence estimates in wild species are often underestima...
BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a severe disease with limited effective therapies, making the discovery of new therapeut...
BACKGROUND: Machine learning (ML) algorithms are increasingly used in healthcare to support clinical decision-making. While models with similar overal...
Accurate prediction of drug response in cancer cells is a fundamental step toward achieving precision medicine and designing personalized therapies. I...
Patients with advanced lung adenocarcinoma have a range of treatment options, including targeted therapy and gene assay-guided chemotherapy. The aim o...
Major depressive disorder (MDD) is a highly heterogeneous condition that limits the reliability of symptom-based diagnosis and treatment selection. In...
Preimplantation genetic testing (PGT) is a critical tool in reproductive medicine for selecting genetically healthy embryos, thereby reducing the risk...
Predicting phenotypes from genomic mutations remains a major genetic challenge. Traditional statistical methods (such as GBLUP and BayesR) have limita...
KBG syndrome (KBGS, OMIM #148050) is a rare genetic disorder caused by heterozygous truncating or missense variants in the ANKRD11 gene or a deletion ...
Despite the recent advancements driven by deep learning, de novo peptide sequencing is still constrained by incomplete peptide fragmentation and insuf...
BACKGROUND: Healthcare Artificial Intelligence (AI) offers transformative potential but often inherits biases from training data, worsening disparitie...
Spinal cord injury (SCI) is a major global health issue with severe complications, yet effective biomarkers remain elusive. We analyzed the GSE226238 ...
OBJECTIVE: Pheochromocytoma and paraganglioma (PPGL) have high genetic predisposition rates. In this multicenter study, we aimed to identify risk-modu...